Viewing Study NCT05257395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-01-27 @ 2:44 PM
Study NCT ID: NCT05257395
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-17
First Post: 2022-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XZP-3287 View
None HR positive Her2 negative recurrent/metastatic breast cancer View